Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice.
暂无分享,去创建一个
Fujun Liu | Lin Yang | Alan H Beggs | Christopher R Pierson | R. Hoffmann | A. Beggs | C. Pierson | J. Lachey | M. Lawlor | C. Hillard | Fujun Liu | Raymond G Hoffmann | Jennifer L Lachey | Michael W Lawlor | K. Yan | Ke Yan | Anna Buj-Bello | Marissa G Viola | Hui Meng | Rachel V Edelstein | Elizabeth J Luna | Alexandra Lerch-Gaggl | Scott Pearsall | Cecilia J Hillard | Marissa G. Viola | A. Lerch-Gaggl | R. Edelstein | H. Meng | Lin Yang | S. Pearsall | A. Buj‐Bello | E. Luna
[1] A. Buj-Bello,et al. Molecular Pathogenesis of Genetic and Inherited Diseases Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice , 2011 .
[2] N. Freedman,et al. Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness that Reflects a Growth Defect and Energy Deficit , 2009, PloS one.
[3] A. Beggs,et al. X-Linked Myotubular and Centronuclear Myopathies , 2005, Journal of neuropathology and experimental neurology.
[4] J. Lachey,et al. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. , 2010, Journal of applied physiology.
[5] O. Meyuhas. Physiological roles of ribosomal protein S6: one of its kind. , 2008, International review of cell and molecular biology.
[6] Ping Huang,et al. Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment. , 2012, The American journal of pathology.
[7] A. Buj-Bello,et al. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase , 2009, Proceedings of the National Academy of Sciences.
[8] I. Conboy,et al. Pharmacological inhibition of myostatin/TGF-β receptor/pSmad3 signaling rescues muscle regenerative responses in mouse model of type 1 diabetes , 2013, Acta Pharmacologica Sinica.
[9] R. Grange,et al. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy. , 2013, Human molecular genetics.
[10] S. Klauck,et al. A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast , 1996, Nature Genetics.
[11] V. Dubowitz,et al. Congenital centronuclear (myotubular) myopathy. A clinical, pathological and genetic study in eight children. , 1985, Brain : a journal of neurology.
[12] L. Bertrand,et al. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy. , 2012, Endocrinology.
[13] A. Beggs,et al. Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy , 2007, Neuromuscular Disorders.
[14] M. Matzuk,et al. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway , 2012, Proceedings of the National Academy of Sciences.
[15] Yanjun Dong,et al. Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction , 2013, PloS one.
[16] Andrew P. Vreede,et al. Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy , 2009, PLoS genetics.
[17] J. Mandel,et al. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin‐proteasome pathways , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] S. Welle,et al. Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[19] Joulia-Ekaza Dominique,et al. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. , 2006 .
[20] W. Mitch,et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] A. Buj-Bello,et al. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis , 2008, Human molecular genetics.
[22] Yuval Dor,et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. , 2005, Genes & development.
[23] G. Taylor,et al. Myotubularin Regulates Akt-dependent Survival Signaling via Phosphatidylinositol 3-Phosphate* , 2011, The Journal of Biological Chemistry.
[24] A. Beggs,et al. Mutations of the slow muscle &agr;-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy , 2002, Neurology.
[25] K. Tsuchida,et al. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. , 2009, American journal of physiology. Endocrinology and metabolism.
[26] C. Wallgren‐Pettersson,et al. Orphanet Journal of Rare Diseases BioMed Central Review , 2008 .
[27] J. Dowling,et al. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. , 2012, Human molecular genetics.
[28] Marcus D. Goncalves,et al. Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition , 2010, PloS one.
[29] S. Cook,et al. Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. , 2009, American journal of physiology. Cell physiology.
[30] A. Goldberg,et al. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. , 2013, The international journal of biochemistry & cell biology.
[31] Hala G. Zahreddine,et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Beggs,et al. Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. , 2011, The Journal of clinical investigation.
[33] E. Bedrick,et al. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. , 2008, Molecular biology of the cell.
[34] Q. Wang,et al. Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation , 2012, The Journal of physiology.
[35] W. Hoogaars,et al. Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins. , 2013, American journal of physiology. Endocrinology and metabolism.
[36] Seumas McCroskery,et al. Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.
[37] W. Engel,et al. The histographic analysis of human muscle biopsies with regard to fiber types , 1969, Neurology.